Creative Biolabs-Immuno-oncology

Anti-CCL2 (clone 1G.1G2E.1G) SynExpress E1-TG-TF-E Modified CD8+ T cells (CAT#: ITS-1224-CR301)

DatasheetDatasheet
Description
This product utilizes Modified CD8+ T cells that have been engineered with our proprietary GeneCircuit technology to specifically target CCL2 (clone 1G.1G2E.1G). We employs the Retrovirus (EF1α-TurboGFP-TFIIA-EcoRI) vector components and the SynExpress system of the Exons Knockout/Adaptive feedback for a robust and sustained response against cancers.
Host
human
Target
CCL2
Clone
1G.1G2E.1G
Species Reactivity
human
Cell Source
Modified CD8+ T cells
Sensor Gene
TurboGFP
Promoter
EF1α
Effector Gene
TFIIA
Insertion Sites
EcoRI
Gene Modification
Knockout
Modification Domain
Exons
Carrier Type
Retrovirus
Transformation Accuracy
0.86
Cell Culture
Adherent Culture
Related Products

For Research Use Only | Not For Clinical Use

Online Inquiry
Copyright © 2026 Creative Biolabs. All Rights Reserved.
ISO 9001 Certified - Creative Biolabs Quality Management System.
Close
Thanksgiving
Thanksgiving